IL74446A - Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide - Google Patents

Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide

Info

Publication number
IL74446A
IL74446A IL74446A IL7444685A IL74446A IL 74446 A IL74446 A IL 74446A IL 74446 A IL74446 A IL 74446A IL 7444685 A IL7444685 A IL 7444685A IL 74446 A IL74446 A IL 74446A
Authority
IL
Israel
Prior art keywords
systemic administration
bopindolol
methysergide
pharmaceutical compositions
administration containing
Prior art date
Application number
IL74446A
Other languages
English (en)
Other versions
IL74446A0 (en
Original Assignee
Sandoz Ag
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag, Lohmann Therapie Syst Lts filed Critical Sandoz Ag
Priority to IL89251A priority Critical patent/IL89251A/xx
Publication of IL74446A0 publication Critical patent/IL74446A0/xx
Priority to IL89251A priority patent/IL89251A0/xx
Publication of IL74446A publication Critical patent/IL74446A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
IL74446A 1984-03-01 1985-02-26 Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide IL74446A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL89251A IL89251A (en) 1984-03-01 1985-02-26 Pharmaceutical compositions for the systemic transdermal administration of pharmacologically active agents
IL89251A IL89251A0 (en) 1984-03-01 1989-02-10 Pharmaceutical compositions for the systemic transdermal administration of pharmacologically active agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH100884 1984-03-01
CH175384 1984-04-06

Publications (2)

Publication Number Publication Date
IL74446A0 IL74446A0 (en) 1985-05-31
IL74446A true IL74446A (en) 1990-11-29

Family

ID=25686369

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74446A IL74446A (en) 1984-03-01 1985-02-26 Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide

Country Status (18)

Country Link
EP (3) EP0315219B1 (ja)
JP (2) JPH0667835B2 (ja)
KR (1) KR920010392B1 (ja)
AT (3) ATE89750T1 (ja)
AU (2) AU578275B2 (ja)
CA (1) CA1257837A (ja)
DE (4) DE3587698T2 (ja)
DK (2) DK175774B1 (ja)
GR (1) GR850507B (ja)
HK (2) HK157896A (ja)
HU (1) HU197847B (ja)
IE (2) IE61754B1 (ja)
IL (1) IL74446A (ja)
MY (1) MY101919A (ja)
NZ (1) NZ211248A (ja)
PH (1) PH24392A (ja)
PT (1) PT80033B (ja)
WO (1) WO1985003878A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
JPH11511731A (ja) * 1995-02-10 1999-10-12 ノエ・クリスチアン 粒状薬剤
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
JP4575632B2 (ja) * 1999-12-14 2010-11-04 帝國製薬株式会社 片頭痛緩和用薬剤
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
JP5758290B2 (ja) * 2009-05-01 2015-08-05 久光製薬株式会社 経皮吸収型製剤
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
WO2018199018A1 (ja) * 2017-04-26 2018-11-01 ニプロ株式会社 経皮吸収型製剤およびその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
CH653256A5 (en) * 1981-04-06 1985-12-31 Sandoz Ag Microemulsion for cutaneous use
ATE20311T1 (de) * 1981-07-08 1986-06-15 Key Pharma Polymerische diffusionsmatritze propranolol enthaltend.
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions

Also Published As

Publication number Publication date
HU197847B (en) 1989-06-28
HK157896A (en) 1996-08-30
DK324687A (da) 1987-06-25
DK502985D0 (da) 1985-10-31
IE850493L (en) 1985-09-01
EP0315219B1 (en) 1993-01-27
DE3587698T2 (de) 1994-04-28
ATE98876T1 (de) 1994-01-15
IL74446A0 (en) 1985-05-31
PH24392A (en) 1990-06-13
ATE103819T1 (de) 1994-04-15
KR850700218A (ko) 1985-12-26
EP0155229A3 (en) 1985-12-11
IE61754B1 (en) 1994-11-30
AU607496B2 (en) 1991-03-07
CA1257837A (en) 1989-07-25
EP0315219A3 (en) 1991-03-06
DK164257B (da) 1992-06-01
EP0315218B1 (en) 1993-12-22
PT80033A (en) 1985-03-01
HK220096A (en) 1997-01-03
GR850507B (ja) 1985-06-28
NZ211248A (en) 1988-10-28
IE940083L (en) 1985-09-01
DE3587048D1 (de) 1993-03-11
DE3587794T2 (de) 1994-08-04
EP0155229A2 (en) 1985-09-18
DE3587698D1 (de) 1994-02-03
AU1662688A (en) 1988-10-20
DE3587794D1 (de) 1994-05-11
AU578275B2 (en) 1988-10-20
DK324687D0 (da) 1987-06-25
EP0315218A2 (en) 1989-05-10
WO1985003878A1 (en) 1985-09-12
EP0155229B1 (en) 1993-05-26
AU4065085A (en) 1985-09-24
DE3587358T2 (de) 1993-11-04
IE81316B1 (en) 2000-09-20
JPS61501324A (ja) 1986-07-03
DK502985A (da) 1985-10-31
EP0315218A3 (en) 1991-03-06
JP2540019B2 (ja) 1996-10-02
EP0315219A2 (en) 1989-05-10
ATE89750T1 (de) 1993-06-15
KR920010392B1 (ko) 1992-11-27
DE3587048T2 (de) 1993-06-03
PT80033B (pt) 1987-10-20
DK175774B1 (da) 2005-02-14
HUT41644A (en) 1987-05-28
JPH0667835B2 (ja) 1994-08-31
JPH0748253A (ja) 1995-02-21
MY101919A (en) 1992-02-15
DE3587358D1 (de) 1993-07-01
DK164257C (da) 1992-10-19

Similar Documents

Publication Publication Date Title
IL74446A (en) Transdermal pharmaceutical compositions for systemic administration containing bopindolol or methysergide
CA2010218A1 (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances
ES2034010T3 (es) Formulacion para la administracion de farmacos por via oral y metodo para prepararla.
IL91047A0 (en) Pharmaceutical compositions containing a zinc complex
CA2265678A1 (en) Electrotransport drug delivery reservoirs containing inert fillers
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
IL86334A (en) Pharmaceutical compositions for transdermal delivery of a pure enantiomer
CA2182812A1 (en) Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
EP0315217A3 (en) Pharmaceutical compositions
IL89251A0 (en) Pharmaceutical compositions for the systemic transdermal administration of pharmacologically active agents

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired